Samsung Changwon Hospital Achieves Top Grade in Coronary Artery Bypass Surgery for 4 Consecutive Years

Winter Season... Caution for Ischemic Heart Diseases Such as Myocardial Infarction and Angina

Samsung Changwon Hospital.

[Asia Economy Yeongnam Reporting Headquarters Reporter Song Jong-gu] Sungkyunkwan University Samsung Changwon Hospital recently achieved a first-grade rating for four consecutive years in the Coronary Artery Bypass Grafting (CABG) appropriateness evaluation conducted by the Health Insurance Review and Assessment Service.

Coronary artery bypass grafting is a surgery that creates alternative blood vessels to allow blood flow around narrowed or blocked heart vessels in patients with ischemic heart diseases such as myocardial infarction and angina. Especially during the cold winter months when temperatures drop sharply, blood vessels constrict and blood pressure rises, increasing the incidence of ischemic heart disease.

This evaluation was conducted on 88 tertiary general hospitals and general hospitals that performed coronary artery bypass grafting on patients hospitalized for ischemic heart disease from October 2020 to September 2021.

Samsung Changwon Hospital, which received excellent evaluations in each category including the rate of coronary artery bypass grafting using the internal thoracic artery, aspirin prescription rate at discharge, and readmission rate within 30 days after discharge, earned the final first-grade rating, proving it is a hospital proficient in coronary artery bypass grafting.

Heart disease ranked as the second leading cause of death in South Korea in 2021.

This content was produced with the assistance of AI translation services.